Recent Articles
-
October 13, 2025 Research Article
Abstract Background: Obesity and arterial hypertension (AHT) are both significant cardiovascular risk factors, with obesity being a major contributor to the development of AHT. AHT in obese patients is particularly challenging to control due to the increas..... -
October 13, 2025 Research Article
Abstract Background and Objective: Atrial fibrillation is the most common cardiac arrhythmia in adults. This study intends to describe the epidemioclinical, therapeutic and evolutionary aspects of atrial fibrillation in the cardiology department of Kara Un..... -
September 04, 2025 Review Article
Abstract Digital stethoscopes represent a major advancement in the field of telemedicine by enabling accurate remote auscultation. Equipped with high-fidelity acoustic sensors, real-time signal processing, and artificial intelligence integration, these device..... -
June 25, 2025 Case Report
Abstract Introduction: Deep hypothermia is used in cardiac surgery to ensure the better protection of cerebral and / or myocardial. The threshold recommended minimum is 18°. It is not devoid of consequences whose care requires a multi factorial. Observat..... -
June 25, 2025 Case Report
Abstract Background: Spontaneous Coronary Artery Dissection (SCAD) is an acute coronary event of uncertain origin. SCAD occurs when the coronary artery wall dissects non-traumatically and non-atherosclerotically, leading to the formation of an intramural he..... -
June 25, 2025 Case Report
Abstract Introduction: Aortic arch interruption is a rare congenital heart malformation, often associated with Di-George syndrome in type B of Celoria-Patton or other cardiac abnormalities. It is a major life-saving neonatal medical and surgical emergency. ..... -
January 31, 2025 Case Report
Abstract Respiratory infection due to COVID-19 has been associated with thrombotic events such as deep vein thrombosis, pulmonary embolism, and, to a lesser extent, arterial thrombosis. Cases of acute aortic occlusion in COVID-19 patients have been previous..... -
January 09, 2024 Research Article
Abstract The anti-obesity agent, semaglutide (2.4 mg/week) was evaluated in a large (n=17,604) multinational randomized trial called SELECT to examine its effects on cardiovascular (CV) outcomes in overweight/obese patients with preexisting CV disease and no .....